PreprintAll rights reservedbioRxiv
Conditional Myeloid-Specific Inhibition of UBE2N Hinders YUMM1.7 Growth
- 1Duke University School of Medicine
Related
- A conditional, myeloid-cell specific estrogen receptor α deletion reprograms the liver immune microenvironment and impedes the growth of colon carcinoma liver metastases
- Small-molecule ACOD1 inhibition attenuates colitis and tumor growth through a shared myeloid mechanism, diverging from genetic deletion
- Chronic Myeloid Leukemia Beyond BCR::ABL1 Inhibition: Resistance Mechanisms and Emerging Therapeutic Modalities.
- Inhibition of PHB2/PINK1-mediated mitophagy potentiates venetoclax activity in acute myeloid leukemia
- From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemia
BibTeX
@misc{schiavone2026conditional,
title = {{Conditional Myeloid-Specific Inhibition of UBE2N Hinders YUMM1.7 Growth}},
author = {K. Schiavone and A. Pecoraro and A. Khawar and K. Zhang and D. Starczynowski and J. Y. Zhang},
howpublished = {bioRxiv},
year = {2026},
month = aug,
doi = {10.64898/2026.08.31.748234},
url = {https://www.biorxiv.org/content/10.64898/2026.08.31.748234v1},
}
RIS
TY - UNPB
TI - Conditional Myeloid-Specific Inhibition of UBE2N Hinders YUMM1.7 Growth
AU - K. Schiavone
AU - A. Pecoraro
AU - A. Khawar
AU - K. Zhang
AU - D. Starczynowski
AU - J. Y. Zhang
PY - 2026
DA - 2026/08/31
PB - bioRxiv
DO - 10.64898/2026.08.31.748234
UR - https://www.biorxiv.org/content/10.64898/2026.08.31.748234v1
ER -